Literature DB >> 17022673

Purification of densonucleosis virus by tangential flow ultrafiltration.

David L Grzenia1, Jonathan O Carlson, Peter Czermak, Binbing Han, Rachel K Specht, S Ranil Wickramasinghe.   

Abstract

Purification at commercial scale of viruses and virus vectors for gene therapy applications and viral vaccines is a major separations challenge. Tangential flow ultrafiltration has been developed for protein purification. Here tangential flow ultrafiltration of parvoviruses has been investigated. Because these virus particles are small (18-26 nm), removal of host cell proteins will be challenging. The results obtained here indicate that 30, 50, and 100 kDa membranes reject the virus particles, whereas 300 kDa membranes allow some virus particles to pass into the permeate. The decrease in permeate flux for the 300 kDa ultrafiltration membrane is much greater than for the 30, 50, and 100 kDa membranes, indicating possible entrapment of virus particle in the membrane pores. The permeate flux and level of protein rejection is strongly affected by the cell culture growth medium. The results indicate that when developing a new process, it is essential that the cell culture and purification operations be developed in parallel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17022673     DOI: 10.1021/bp060077c

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  3 in total

1.  Purification of Bionanoparticles.

Authors:  L Pedro; S S Soares; G N M Ferreira
Journal:  Chem Eng Technol       Date:  2008-05-27       Impact factor: 1.728

Review 2.  Downstream processing of cell culture-derived virus particles.

Authors:  Michael W Wolf; Udo Reichl
Journal:  Expert Rev Vaccines       Date:  2011-10       Impact factor: 5.217

3.  Tangential Flow Filtration for the Concentration of Oncolytic Measles Virus: The Influence of Filter Properties and the Cell Culture Medium.

Authors:  Daniel Loewe; Tanja A Grein; Hauke Dieken; Tobias Weidner; Denise Salzig; Peter Czermak
Journal:  Membranes (Basel)       Date:  2019-11-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.